2013
-
ERT Delivers In-country Support for Japan-Based Clinical Trials
ERT Continues to Invest in Japanese Resources to Better Serve Trial Sponsors and Investigators
-
ERT Introduces Ambulatory Blood Pressure Monitoring Solution
Centralized ABPM Solution Delivers Data Accuracy and Increased Trial Efficiencies
-
ERT Concludes Successful Annual Conference
PROFICIENCY™ 2013 Annual Conference Addresses how COAs Meet Stakeholders’ Needs
-
Oxford’s Electronic Endometriosis Survey brings Women’s Health into Focus
Isis Outcomes partners with ERT and PharmaQuest to migrate PRO instrument
-
ERT Scientists to be Featured Presenters at Industry Conferences
2012
-
ERT Opens Registration for PROFICIENCY™ 2013 Annual Conference
International Biopharma and Regulatory Professionals Deliver Practical Information on How High-Quality Patient Safety & Efficacy Data Can Demonstrate Value throughout the Product Lifecycle
-
ERT Named Life Sciences Company of the Year
Pittsburgh Technology Council Awards ERT based on Strong Growth, Financial Stability, and Product Advancements
-
ERT Concludes Successful Regional Conference Series
Ongoing Opportunities to Meet with Industry Leading Scientists and Regulatory Experts at Upcoming Events
-
ERT Secures European Outsourcing Award for Pioneering COPD Study with UCLA
Company recognized for ground-breaking program that utilizes home-based respiratory devices for the early identification of COPD exacerbations to improve patient quality of life and reduce demand for medical care
-
ERT Named as Finalist in Pittsburgh Technology Council Tech 50 Awards
2011
-
invivodata Delivers Expanded Asian Language Help Desk Support
Expansion of Established Service Enables Successful ePRO Trials throughout Asia
-
ERT to Present at the Citi 2011 Global Health Care Conference on November 15, 2011
-
invivodata and PRO Consulting Extend Educational Webinar Series
Series Launches with Overview of Recent FDA Workshop on Clinical Outcome Assessments
-
Smart Business publishes, “Doug Engfer has established invivodata, inc. for long-term growth”
-
ERT Reports Third Quarter 2011 Operating Results
- Record revenues of $48.1 million
- Diluted net income per share - GAAP of $0.09 / Non-GAAP of $0.11
- Record bookings of $78.4 million
- Record backlog of $343.8 million
